HealthQuest Capital and Great Point Partners Invest Growth Equity in Cellipont Bioservices; Darren Head Named CEO

Great Point Partners Makes Growth Investment in iXCells Biotechnologies

September 29, 2022

Biotechnology

Great Point Partners, a Greenwich, CT-based healthcare-focused private investment firm, has made a growth investment in San Diego-based iXCells Biotechnologies. The capital will be used to expand iXCells' operational capacity, broaden its product and service offering (including bioanalytical capabilities) and support growth into adjacent high-growth end markets such as personalized medicine and rare disease research.

QHP Capital Acquires Applied StemCell

October 9, 2023

Biotechnology

QHP Capital has acquired Applied StemCell, a Milpitas, California–based cell and gene therapy CRO/CDMO that provides iPSC and TARGATT gene‑editing platforms for biopharma and research clients. QHP said the acquisition will provide strategic capital and operating support to accelerate ASC's commercial expansion and scale its manufacturing and service capabilities for the cell and gene therapy market.

Warburg Pincus Makes Growth Investment in Quantum Health; Great Hill Partners Retains Stake

November 20, 2020

Healthcare Services

Warburg Pincus has made a significant growth investment in Quantum Health, partnering with existing investor Great Hill Partners (which will retain a significant stake) to accelerate the company's technology platform and service delivery. Quantum Health, a Columbus, Ohio-based healthcare navigation and care coordination provider serving more than 1.7 million plan participants across 400+ employers, will continue to be led with Kara Trott remaining as Chair.

Great Point Partners Completes Growth Recapitalization of Velentium

September 29, 2021

Medical Devices

Great Point Partners completed a growth recapitalization of Houston-based Velentium, a professional engineering and contract medical device manufacturer. The investment will fund Velentium's expansion initiatives — including tuck-in acquisitions and enhanced engineering and manufacturing capabilities — while preserving the company's quality and culture.

Catalent Acquires MaSTherCell Global from Great Point Partners and Co-investors

February 3, 2020

Biotechnology

Catalent Pharma Solutions has signed a definitive agreement to acquire MaSTherCell Global, a cell and gene therapy CDMO that Great Point Partners had invested in alongside Orgenesis and SFPI-FPIM. MaSTherCell, headquartered in Gosselies, Belgium with a U.S. facility in Houston, Texas, expands Catalent's cell and gene therapy development and manufacturing capabilities and adds significant European and U.S. capacity.

Peloton Equity Leads Growth Investment in OnPoint Healthcare Partners

January 25, 2024

Healthcare Services

Peloton Equity led a growth equity investment in OnPoint Healthcare Partners, with participation from Fort Maitland Capital, to accelerate OnPoint’s product roadmap, sales and marketing, and customer support. OnPoint, an AI-enabled healthcare technology and services provider founded in 2020, will add Peloton partners to its board as it scales its IRIS Cloud platform and RCM/documentation services from its headquarters in Irving, Texas.